Table 3. TLS prophylactic strategies... | American Society of Hematology

Table 3.

TLS prophylactic strategies used in venetoclax escalation events in which TLS developed

Prophylactic agent used	Number of patient-events
Allopurinol	8 (80%)
Febuxostat	0
IV hydration	4 (40%)
IV diuretic use	1 (10%)
Rasburicase	0
Phosphate binders	5 (50%)
Ion exchange resins	0

Prophylactic agent used	Number of patient-events
Allopurinol	8 (80%)
Febuxostat	0
IV hydration	4 (40%)
IV diuretic use	1 (10%)
Rasburicase	0
Phosphate binders	5 (50%)
Ion exchange resins	0